Your browser doesn't support javascript.
loading
Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter, A; Licciardi-Fernandez, M J; Burmann, S-N; Burkert, B; Oellig, F; Michalowitz, A-L.
Afiliación
  • Kreuter A; Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
  • Licciardi-Fernandez MJ; Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
  • Burmann SN; Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
  • Burkert B; Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
  • Oellig F; Institute of Pathology, Mülheim an der Ruhr, Germany.
  • Michalowitz AL; Department of Dermatology, Venereology and Allergology, HELIOS St Elisabeth Hospital Oberhausen, University Witten/Herdecke, Witten, Germany.
Clin Exp Dermatol ; 47(1): 161-163, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34291477

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Erupciones por Medicamentos / COVID-19 / Vacuna BNT162 Límite: Aged / Humans / Male Idioma: En Revista: Clin Exp Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Lupus Eritematoso Cutáneo / Erupciones por Medicamentos / COVID-19 / Vacuna BNT162 Límite: Aged / Humans / Male Idioma: En Revista: Clin Exp Dermatol Año: 2022 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido